CD80 and diffuse large B-cell lymphoma: As shown in the heatmap showed (Figure 1), all B7 family members reported in the literature other than B7-H5 were more highly expressed in diffuse large B cell lymphoma (DLBCL), suggesting that these molecules may play vital roles in lymphoma immunity, explaining the poor effect of PD-1/PD-L1 therapy.